| 000 | 01902 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516055426.0 | ||
| 264 | 0 | _c20111129 | |
| 008 | 201111s 0 0 eng d | ||
| 022 | _a1532-2157 | ||
| 024 | 7 |
_a10.1016/j.ejso.2011.08.138 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClasse, J M | |
| 245 | 0 | 0 |
_aPrognostic factors for patients treated for a recurrent FIGO stage III ovarian cancer: a retrospective study of 108 cases. _h[electronic resource] |
| 260 |
_bEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology _cNov 2011 |
||
| 300 |
_a971-7 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xmortality |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xmortality |
| 650 | 0 | 4 |
_aOvariectomy _xmethods |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSurvival Rate _xtrends |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aJaffre, I | |
| 700 | 1 | _aFrenel, J S | |
| 700 | 1 | _aBordes, V | |
| 700 | 1 | _aDejode, M | |
| 700 | 1 | _aDravet, F | |
| 700 | 1 | _aFerron, G | |
| 700 | 1 | _aMarchal, F | |
| 700 | 1 | _aRigaud, D Berton | |
| 700 | 1 | _aLoussouarn, D | |
| 700 | 1 | _aCampion, L | |
| 773 | 0 |
_tEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology _gvol. 37 _gno. 11 _gp. 971-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejso.2011.08.138 _zAvailable from publisher's website |
| 999 |
_c21182560 _d21182560 |
||